CPRX Net Income Growth
Catalyst Pharmaceuticals Inc · Net Income Growth
CPRX Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported12.15%period ending
CPRX TTM Net Income YoY % (-434.47% → 12.15%)
Year-over-year change
High-resolution chart · PNG
CPRX net income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Net Income Growth |
|---|---|
| 12.1469% | |
| 30.7751% | |
| 52.3589% | |
| 206.1894% | |
| 203.0714% | |
| 129.5043% | |
| 130.1804% | |
| -41.0216% | |
| -34.4939% | |
| -14.0457% | |
| -7.2926% | |
| 112.0243% | |
| 120.6081% | |
| 110.4225% | |
| 60.819% | |
| -26.9671% | |
| -37.6074% | |
| -47.3455% | |
| -41.7842% | |
| 78.6652% | |
| 68.1656% | |
| 135.2387% | |
| 656.6758% | |
| 447.3822% | |
| 248.3545% | |
| 193.7413% | |
| 137.9486% | |
| 43.3687% | |
| -51.2035% | |
| -84.6775% | |
| -44.8197% | |
| -25.1472% | |
| -8.4505% | |
| -1.8809% | |
| 12.8587% | |
| 16.0985% | |
| 12.6459% | |
| 10.6782% | |
| -10.1434% | |
| -9.4791% | |
| -18.1243% | |
| -30.4589% | |
| -33.9034% | |
| -29.3701% | |
| -20.2988% | |
| -27.5983% | |
| -22.9592% | |
| -88.1869% | |
| -200.5698% | |
| -198.1709% | |
| -71.237% | |
| -56.1535% | |
| 20.654% | |
| 36.2174% | |
| -33.2192% | |
| -6.9105% | |
| -33.1523% | |
| -59.5244% | |
| -7.3923% | |
| 5.773% | |
| 14.7905% | |
| 44.6788% | |
| 54.8241% | |
| 57.6839% | |
| 56.2448% | |
| 31.451% | |
| -26.6147% | |
| -102.0326% | |
| -168.6314% | |
| -155.2148% | |
| -97.21% | |
| -24.7176% | |
| -22.5689% | |
| -51.6601% | |
| -18.9103% | |
| -102.7858% | |
| -42.6287% | |
| 5.398% | |
| -94.8733% | |
| -40.1343% | |
| -140.0087% | |
| -434.4741% |